Select Committee on Health Fourth Report


2  History

July 1999—ACAD, Europe's first dedicated elective treatment centre, opened at Central Middlesex Hospital

April 2002—NHS Treatment Centre programme announced in Delivering the NHS Plan: next steps on investment, next steps on reform

December 2002—ISTC programme announced in Growing Capacity: Independent Sector Diagnosis and Treatment Centres

September 2003—first ISTC contracts signed

October 2003—first ISTC opened at Daventry (Birkdale Ltd)

March 2005—second phase of ISTCs announced

6. The reasons for separating elective and emergency care were vividly brought to our attention by the President of the Royal College of Surgeons. He described a situation in which he had been scheduled to perform three hernia operations and two laparoscopic cholecystectomies in an afternoon, while supervising trainees, but the admission of an emergency case had required the use of the operating theatre in which he had been scheduled to work. The hernia patients had to be sent home.[2]

NHS Treatment Centres

7. Various ways of 'ring-fencing' elective procedures have been attempted, including setting aside beds in wards specifically for this purpose. Such measures were unsuccessful because the beds were often needed by emergency patients. Treatment centres have the great advantage that they cannot be used for emergency care.[3]

8. Following a decade's pressure from many leading members of the medical profession to establish treatment centres, ACAD (the Ambulatory Care and Diagnostic Centre) was opened at the Central Middlesex Hospital in 1999. A further 15 schemes were introduced before a systematic programme of treatment centres was announced in 2002.

9. In April of that year, the Department of Health published Delivering the NHS Plan: next steps on investment, next steps on reform. One of the innovations contained in the document was the establishment of NHS Treatment Centres to perform a high volume of relatively straightforward elective procedures in a predictable flow. These centres, originally referred to as Diagnostic and Treatment Centres (DTCs), were intended "to help meet NHS waiting time reductions and provide more rapid, convenient and improved outpatient and diagnostic services in the community […] diversify service provision and, once again, relieve pressure on mainstream NHS hospitals".[4] The treatment centres which already existed were absorbed into the NHS Treatment Centre programme.

10. The original NHS Treatment Centre programme comprised 46 treatment centres.[5] Many of the larger centres were intended, in part, to facilitate the achievement of NHS Plan targets and were accordingly designed to have spare capacity. The business cases for these treatment centres assumed that they would perform additional work for Trusts other than their hosts. However, all NHS Treatment Centres received and continue to receive funding solely on the basis of number of patients seen.[6]

11. In 2002, a group of NHS chief executives and clinicians, some from the NHS Treatment Centres, established NHS Elect to promote innovation and deliver a high standard of care. NHS Elect "currently supports 18 elective care providers as part of the formal infrastructure of support provided to the NHS by the Department of Health Short-Stay Elective Care Programme".[7] It is funded by the Department of Health and by a small subscription from the sponsoring NHS Trusts.[8]

BUPA at Redwood

12. In addition to the NHS Treatment Centre programme, and predating the ISTC programme, an independent diagnostic and treatment centre was opened at Redwood in Surrey in December 2002 by BUPA, in partnership with the local NHS trust. The centre, which we visited, employs both dedicated BUPA staff and NHS employees on secondment, and is based on the same site as an NHS hospital, the East Surrey Hospital, with a physical link to that facility, thereby, we were told, fostering a spirit of co-operation.

ISTCs: Phase 1

13. In December 2002, eight months after announcing its programme of NHS Treatment Centres, the Department of Health published Growing Capacity: Independent Sector Diagnosis and Treatment Centres, which launched a procurement exercise to acquire from the independent sector additional capacity beyond that provided by the NHS.[9] The total cost of Phase 1 will be £1.7 billion. The Department has referred to two main and distinct purposes, which have often and misleadingly been conflated: to increase the surgical capacity available to the NHS; and to involve the independent sector in an increasingly mixed health economy with all the benefits the Department claims this will bring.[10]

14. In its memorandum to the Committee, the Department claimed that the exercise was undertaken in response to local capacity analyses.[11] This claim was much disputed (see paragraph 34 below). We were told that the analyses were conducted by Strategic Health Authorities (SHAs), in consultation with their Primary Care Trusts (PCTs), in which the SHAs had identified any anticipated gaps in their capacity required to achieve the waiting time targets laid down for 2005.[12]

15. We asked the Secretary of State for Health, the Rt Hon Patricia Hewitt MP, why the additional capacity which SHAs had identified as being required could not be provided by further investment in the NHS Treatment Centre programme and NHS services more generally. She told us:

We needed very rapidly to bring new capacity into the NHS, and my predecessors, I think quite rightly, made the decision to do that, first of all, by expanding capacity within the NHS itself, secondly to expand capacity through the ISTC programme.[13]

16. The Secretary of State continued:

It was […] through the ISTC programme that we challenged the exceptionally high prices of the private sector in the United Kingdom, got those prices down, brought the prices down for the spot purchasing (thus increasing value for money) […] challenging the incumbents (uncomfortably for them, perhaps) within the UK private sector and introduced a new element of dynamism into the NHS but, more broadly, into the health care system.

The precise objectives behind the introduction of the ISTC programme, and the way in which they developed and changed over time, are dealt with in greater detail in Chapter 3.

17. The Department informed us that once local studies had established the need for new capacity, it followed the process described below. The programme was advertised in December 2002, attracting expressions of interest from 147 companies, to whom Pre-Qualification Questionnaires (PQQs) and Memoranda of Information (MOIs) were then issued. The responses to the PQQs were received by the Department in February 2003 and pre-qualification was decided by assessing the technical and financial capability and capacity of potential bidders. A short-list was then drawn up and those companies were issued with Invitations to Negotiate (ITNs) in April 2003, to be returned during the following two months.[14]

18. Once the responses to the ITNs had been received by the Department of Health, the Bid Evaluation Phase began, consisting of six stages:

  • Stage 1: Bid Receipt;
  • Stage 2: Evaluation;
  • Stage 3: Clarification;
  • Stage 4: Bidder Convergence;
  • Stage 5: Final Evaluation, and
  • Stage 6: Preferred Bidder Selection.

After the Preferred Bidder (and, where appropriate, a Reserve Bidder) had been selected, negotiations began to finalise the details of the contract.[15]

19. The preferred bidders for most of the ISTC contracts were announced in September 2003. The Department of Health's memorandum to the Committee stated that the bidders had to "meet the core clinical standards required by the NHS, provide high standards of patient care […] and provide good value for money to NHS commissioners".[16] The contracts had a number of noteworthy features, including the 'additionality' provision and the 'take or pay' elements.[17] There was no requirement to train staff.

20. The table below lists the 29 Phase 1 ISTCs which are currently or will shortly be operating:
Treatment Centre Operational Status Casemix
Ophthalmic ChainFull Service Ophthalmology
East CornwallFull Service Ophthalmology, General Surgery, Gastroenterology, Gynaecology, Urology
East LincolnshireFull Service Ophthalmology, Urology, Hernias, Varicose Veins, Colonoscopies and Minor Skin
West LincolnshireFull Service Ophthalmology, Gastroscopies, Colonoscopies, Orthopaedics, Urology and Minor Skin
North Oxford (Horton) Full ServiceOrthopaedics
North and East Yorkshire and North Lincolnshire Full ServiceGeneral Surgery, Trauma and Orthopaedics
SouthamptonFull Service Orthopaedics
NorthumberlandFull Service Upper GI Scopes, Hernias, Varicose Veins, Minor Skin
TV3500Full Service General Surgery, Urology, Trauma and Orthopaedics, Dermatology, Gynaecology
KidderminsterFull Service Orthopaedics
WycombeFull Service Diagnostics
MedwayFull Service General Surgery, Gastroenterology, ENT, Orthopaedics, Urology, Oral Surgery, Endoscopies
PortsmouthFull Service Walk-In Centre/Minor Injuries Unit, Day Surgery, Ophthalmology, Diagnostics
BradfordFull Service General Surgery, Gastroenterology, ENT, Gynaecology, Ophthalmology, Orthopaedics, Plastic Surgery, Urology, Oral Surgery, Diagnostics
Trent & South Yorkshire Full ServiceOrthopaedics
DaventryFull Service Ophthalmology, Orthopaedics, Plastic Surgery, Oral Surgery, Upper GI Endoscopies
Shepton MalletFull Service Orthopaedics, Ophthalmology, General Surgery and Endoscopies
Greater Manchester Full ServiceOrthopaedics, General Surgery and ENT
PlymouthFull Service Orthopaedics
Cheshire & Merseyside MobilisationOrthopaedics
NottinghamMobilisation Orthopaedics, Gynaecology, General Surgery, Dermatology, Endoscopies, Oral and Maxillofacial Surgery, Vascular Surgery, Chronic Pain and Diagnostics
MaidstoneMobilisation Chemotherapy, Minor Surgery and Diagnostics
Outer North-East London (BHRT) MobilisationOphthalmology, Orthopaedics, ENT, Oral Surgery, General Surgery and Urology
BrightonMobilisation Orthopaedics
BurtonMobilisation General Surgery, ENT, Gynaecology, Ophthalmology, Orthopaedics, Plastic Surgery, Urology, Oral Surgery, Rheumatology, Pain Procedures
GC4 West SurreyUnder Negotiation Orthopaedics
Lister Surgi Centre Under NegotiationPaediatrics, ENT, Endoscopies, Urology, Ophthalmology, Gynaecology and Other Specialities
Hemel Hempstead Surgi Centre Under NegotiationPaediatrics, ENT, Endoscopies, Urology, Ophthalmology, Gynaecology and Other Specialities
HavantNot Operational Diagnostics

Data from Department of Health, see Ev 16 Volume II[18]

General Supplementary Contracts

21. Separate from the ISTC programme was another system of private sector-provided NHS elective care, the so-called General Supplementary Contracts (GSup). Under GSup-1 in 2005, Nuffield and Capio provided extra activity in ear, nose and throat (ENT), general surgery, urology and orthopaedics, in areas with especially long waiting times. GSup-2, a six-month contract beginning in July 2005, concentrated on orthopaedics.

ISTCs: Phase 2

22. In March 2005, the Department of Health announced a substantial second wave of procurement from the independent sector. Phase 2 was to consist of diagnostic and elective work, including an Extended Choice Network (ECN) of independent sector providers to deliver procedures on an ad hoc basis. £2.75 billion is to be spent on the elective element and £1 billion on the diagnostics.[19] The procedures will be performed in a variety of settings, including existing ISTCs, new-build facilities, refurbishments and NHS sites. The same process for choosing bidders was used for Phase 2 as in Phase 1.

23. There has been confusion about the scale and nature of Phase 2. When the Secretary of State gave oral evidence on 26 April 2006, she told us that ITNs had been issued for 12 elective schemes, in two tranches, and that responses had been received for five of those bids.[20] However, the Health Service Journal reported the next day that Phase 2 had originally comprised 24 schemes, of which seven had subsequently been scrapped, with only 17 proceeding (perhaps with some delay).[21] The Secretary of State conceded in a letter to the Committee that Phase 2 would indeed probably consist of 17 schemes.[22] We were eventually able to clarify the situation in a further evidence session with the Commercial Director: the Secretary of State had referred on 26 April to 12 schemes for which ITNs had been issued, but there were a further 12 schemes which, at that time, were under consideration within the Department. Following that consideration, it was decided not to proceed with seven of them, but the other five were still being assessed. Subsequently, the Department sent us a supplementary memorandum indicating why the seven schemes were not going ahead. Therefore, Phase 2 is likely to consist of 17 elective schemes. In addition, there will be seven regional diagnostic schemes.[23]

24. The Department told the seven failed bidders:

It was necessary to review the resulting, more detailed makeup of these schemes against its objectives, the changing situation in health economies, and commercial criteria. As a result of this review, Ministers have decided that these particular schemes will not go ahead.

Nevertheless, all SHAs affected by the cancellation of these seven schemes would be obliged by the Department to make more independent sector provision available to their NHS patients in a variety of ways.[24] The Department of Health remains committed to investing £550 million each year in procurement from the independent sector, seemingly regardless of the what local health economies decide they need.[25] The total budget for Phase 2 over five years will therefore remain £2.75 billion for the elective component and £1 billion for diagnostics.[26] The apparent contradiction between leaving it to local health economies to decide on Phase 2 schemes and the determination to spend almost £3 billion on independent provision is considered in Chapter 4.


2   Q 108 (Mr Ribeiro) Back

3   Ev 136 Volume II Back

4   Department of Health, Delivering the NHS Plan: next steps on investment, next steps on reform, April 2002, p 26 Back

5   A list of NHS Treatment Centres can be found in the attached Annex on p 48 Back

6   Ev 207 Volume III Back

7   NHS Elect members are identified in the Annex on p 48 Back

8   For more information on NHS Elect see www.nhselect.org.uk Back

9   Department of Health, Growing Capacity: Independent Sector Diagnosis and Treatment Centres, December 2002 Back

10   See para 51 Back

11   Ev 1 Volume II Back

12   Q 4 Back

13   Q 537 Back

14   Ev 148 Volume III Back

15   ibid. Back

16   Ev 1 Volume II Back

17   See Glossary of Terms on p 50 Back

18   We are concerned by the inaccuracies in evidence concerning Kidderminster provided by the Department of Health at Ev 26, Volume II, lines 2-4, which are incorrect or out-of-date and therefore misleading. Back

19   Ev 1 Volume II Back

20   Q 585 Back

21   Helen Mooney, "Treatment centre programme in disarray as contracts axed", Health Service Journal, 27 April 2006, p 5 Back

22   Ev 150 Volume III Back

23   Qq 617-19 Back

24   Ev 150 Volume III Back

25   ibid. Back

26   Ev 1 Volume II Back


 
previous page contents next page

House of Commons home page Parliament home page House of Lords home page search page enquiries index

© Parliamentary copyright 2006
Prepared 25 July 2006